A trial looking at neratinib and capecitabine for breast cancer that has spread (NALA)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is comparing neratinib and capecitabine with lapatinib and capecitabine for breast cancer that has spread (secondary breast cancer). The trial is for people whose secondary breast cancer has large amounts of the protein HER2 (HER2 positive).

Recruitment start: 1 March 2013

Recruitment end: 23 June 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Steven Chan

Supported by

NIHR Clinical Research Network: Cancer

Puma Biotechnology

Last reviewed: 24 Jul 2017

CRUK internal database number: 11137

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.